Literature DB >> 15800706

The prognostic role of clinical, morphological and molecular markers in oral squamous cell tumors.

Zs Németh1, N Velich, S Bogdan, M Ujpál, G Szabó, Z S Suba.   

Abstract

Despite of considerable advances in the diagnostic and therapeutic possibilities, the prognosis of epithelial tumors in the oral cavity is still very poor. A knowledge of the prognostic factors at the beginning of treatment is therefore indispensable for determination of the appropriate therapy for the given patient. These factors may be linked to the patient (e.g. age, sex, general condition and immunological parameters) or to the tumor localization. A survey of the literature reveals that the TNM stage, the grade, the mode of invasion and the depth of the tumor infiltration are generally the most important factors influencing the fate of the patient. The prognosis depends primarily on the clinicopathological parameters, though even if they are known, it is not possible to screen out those patients who are at particular risk of a relapse. During the past 10 years, study of the DNA content distribution, the proliferation markers and certain oncogenes has come into the focus of attention; great interest is also shown in the extracellular matrix components and the metalloproteinases, which play key roles in the invasion and metastasis formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15800706

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  8 in total

1.  Expression of ets-1 is not affected by N-ras or H-ras during oral oncogenesis.

Authors:  Eleftherios Vairaktaris; Georgios Papageorgiou; Spyridoula Derka; Panagiota Moulavassili; Emeka Nkenke; Peter Kessler; Stavros Vassiliou; Veronica Papakosta; Sofia Spyridonidou; Antonis Vylliotis; Andreas C Lazaris; Sofia Anagnostopoulou; Constantinos Mourouzis; Christos Yapijakis; Efstratios Patsouris
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-28       Impact factor: 4.553

2.  Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.

Authors:  Jun Sato; Yoshimasa Kitagawa; Yutaka Yamazaki; Hironobu Hata; Takuya Asaka; Masaaki Miyakoshi; Shozo Okamoto; Tohru Shiga; Masanobu Shindoh; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-28       Impact factor: 9.236

3.  A novel approach to biomarker discovery in head and neck cancer using an autoantibody signature.

Authors:  N Russo; X Wang; M Liu; R Banerjee; M Goto; C Scanlon; T Metwally; R C Inglehart; A Tsodikov; S Duffy; E Van Tubergen; C Bradford; T Carey; G Wolf; A M Chinnaiyan; N J D'Silva
Journal:  Oncogene       Date:  2012-11-19       Impact factor: 9.867

4.  Elucidating the mechanism of miRNA-214 in the regulation of gingival carcinoma.

Authors:  Yu Gong; Hongli Yang; Xin Tian
Journal:  Exp Ther Med       Date:  2017-03-24       Impact factor: 2.447

5.  Neoadjuvant chemotherapy: does it have benefits for the surgeon in the treatment of advanced squamous cell cancer of the oral cavity?

Authors:  Lajos Olasz; József Szalma; Eniko Orsi; Tamás Tornóczky; Tamás Markó; Zoltán Nyárády
Journal:  Pathol Oncol Res       Date:  2009-09-12       Impact factor: 3.201

6.  HOXB5 expression in oral squamous cell carcinoma.

Authors:  Renata Tucci; Marcia Sampaio Campos; Luciana Fasanella Matizonkas-Antonio; Marcelo Durazzo; Décio dos Santos Pinto Junior; Fabio Daumas Nunes
Journal:  J Appl Oral Sci       Date:  2011-04       Impact factor: 2.698

7.  Does diagnostic accuracy of surgeon's perception outweigh frozen section analysis in determining intraoperative clear mucosal surgical margins in oral squamous cell carcinoma patients?

Authors:  Chetan Gupta; Nitin Bhola; Anendd Jadhav; Apoorva Mishra; Pawan Hingnikar; Chinmay Ghavat
Journal:  Natl J Maxillofac Surg       Date:  2020-12-16

8.  Salivary Metabolomics for Prognosis of Oral Squamous Cell Carcinoma.

Authors:  Shigeo Ishikawa; Masahiro Sugimoto; Tsuneo Konta; Kenichiro Kitabatake; Shohei Ueda; Kaoru Edamatsu; Naoki Okuyama; Kazuyuki Yusa; Mitsuyoshi Iino
Journal:  Front Oncol       Date:  2022-01-05       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.